AstraZeneca cancer drug, companion test approved
Friday, December 19, 2014 - 15:00
in Health & Medicine
TRENTON, N.J. (AP) -- U.S. regulators on Friday granted accelerated approval to the first in a new class of targeted drugs for ovarian cancer, Lynparza from British drugmaker AstraZeneca PLC....
